Search results
May 7, 2024 · Novartis Philippines. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- About
The ability to attract, grow and keep talented people is...
- Novartis in Philippines
In 2023, the full Novartis portfolio of medicines reached 1...
- Healthcare Professionals
Healthcare Professionals Resources for the Philippines...
- News
News - Novartis Philippines
- Contact
Zuellig Pharma Corporation (ZPC) is the exclusive...
- Patient Resources
Unblocked Heart Health Take control of your health and...
- ESG
ESG - Novartis Philippines
- Stories
Asia Pacific Patient Innovation Summit: Philippines Outcome...
- About
In 2023, the full Novartis portfolio of medicines reached 1 million Filipino patients. Filipino patients who took Novartis medicines gained a total of 7,355 quality-adjusted life-year (QALYs). QALY is a generic measure of disease burden, including both the quality and the quantity of life lived.
Zuellig Pharma Corporation (ZPC) is the exclusive distributor of Novartis products in the Philippines. You may contact ZPC at +63 2 8902 2222. For more information on the availability of Novartis products, call +63 2 7368 7777.
Novartis Medhub Philippines, an exclusive online medical content hub where physicians can access educational information, downloadable materials, videos & more.
Aug 23, 2021 · Substantial contributions of Novartis to support the Philippine economy and improve health outcomes of Filipinos were highlighted during a recent online business forum. “In 2020, Novartis contributed USD 158.6 million [PHP 7.6 billion] to the Gross Domestic Product of the Philippines.
Novartis Healthcare Philippines, Inc. is one of the leading research-based pharmaceutical companies in the country, providing innovative, life-saving medicines to Filipinos. See our community...
Use Ruxolitinib (JAKAVI®) as soon as MF patients are eligible to bring the most benefit to their lives 1-4. Patients with MF face increasingly debilitating symptoms as the disease progresses, with symptoms that negatively affect quality of life (QoL) 5-6.